未知股票 RUBY 深 沪
等待开盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 9048.30万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 1.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ruby Mills Faces Fund Attachment by Enforcement Directorate
Ruby Mills Limited ( ($IN:RUBYMILLS) ) has provided an update. Ruby Mills Limit...
10-25 22:14
Reported Earlier: Vertex Advances Povetacicept Program With FDA Rolling Review For IgAN; Initiates OLYMPUS, A Phase 2b/3 Pivotal Study Of Pove For The Treatment Of pMN, And Announces Updated Date From RUBY-3 trial Accepted For Late-Breaking American Society Of Nephrology 2025 Presentation
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year -- Second pivotal development program of
10-17 23:34
Ruby Mills Limited Concludes 109th AGM with Key Resolutions
An announcement from Ruby Mills Limited ( ($IN:RUBYMILLS) ) is now available. R...
09-09 23:25
Alligator Bioscience Secures RUBY™ Antibody Evaluation Agreement
Alligator Bioscience AB ( ($SE:ATORX) ) has shared an announcement. Alligator B...
09-02 22:33
Ruby Mills Approves Q2 2025 Financial Results
The latest update is out from Ruby Mills Limited ( ($IN:RUBYMILLS) ). The Ruby ...
08-14 22:22
Financial Analysis: Rubius Therapeutics (NASDAQ:RUBY) Vs. Cardiol Therapeutics (NASDAQ:CRDL)
Rubius Therapeutics (NASDAQ:RUBY – Get Rating) and Cardiol Therapeutics (NASDAQ...
2023-03-07 13:52
雅培金融管理公司出售的Rubius Therapeutics, Inc.（纳斯达克股票代码：RUBY）股票
Abbot Financial Management Inc. trimmed its stake in shares of Rubius Therapeut...
2023-02-24 01:33
比较 Abcam（纳斯达克股票代码：ABCM）和 Rubius Therapeutics（纳斯达克股票代码：
Abcam (NASDAQ:ABCM – Get Rating) and Rubius Therapeutics (NASDAQ:RUBY – Get Rat...
2023-02-21 14:21
X4制药盘中异动 快速上涨5.00%报0.992美元
北京时间2023年02月15日04时59分，X4制药（XFOR.us）股票出现异动，股价急速上涨5.00%。截至发稿，该股报0.992美元/股，成交量34.0...
2023-02-15 06:14
内克塔治疗盘中异动 快速下挫5.03%
北京时间2023年02月15日01时24分，内克塔治疗（NKTR.us）股票出现异动，股价快速下挫5.03%。截至发稿，该股报2.93美元/股，成交量45.7...
2023-02-15 02:08
